VFA
CRBP icon

Virtus Fund Advisers’s Corbus Pharmaceuticals CRBP Stock Holding History

Virtus Fund Advisers’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$337K Buy
+1,581
New +$338K ﹤0.01% 425

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus Fund Advisers's CRBP Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Corbus Pharmaceuticals (CRBP) in Q4 2017: 1,581 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #425 among its holdings.

88 funds tracked by Wall St. Rank hold CRBP as of Q4 2017.

  • Virtus Fund Advisers held 1,581 shares of Corbus Pharmaceuticals worth $337K as of Q4 2017.
  • Corbus Pharmaceuticals was a new Virtus Fund Advisers position in Q4 2017.
  • Corbus Pharmaceuticals made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #425 holding.
  • 88 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.